LFST - Company ID 0001845257
The table below shows LifeStance Health Group, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $403.48M | $363.81M | $345.31M | $332.97M | $312.72M | $312.33M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
LifeStance Health Group, Inc. reported annual revenue of $1.42B for fiscal year 2025. That is up 13.9% from $1.25B in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $212.52M (FY 2019) to $1.42B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $100.33M |
| $95.61M |
| $97.38M |
| $94.43M |
| $85.27M |
| $95.15M |
| Operating income | $22.28M | $7.41M | -$2.95M | $1.60M | $47.00K | -$15.95M |
| Income tax | $5.52M | $3.50M | -$2.15M | -$2.18M | $575.00K | $656.00K |
| Net income | $14.24M | $1.08M | -$3.79M | $709.00K | $709.00K | -$23.28M |
| EPS (diluted) | - | - | - | - | - | - |